OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
Krista L. Lanctôt, Julie Hviid Hahn‐Pedersen, C Eichinger, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 49
Krista L. Lanctôt, Julie Hviid Hahn‐Pedersen, C Eichinger, et al.
The Journal of Prevention of Alzheimer s Disease (2023)
Open Access | Times Cited: 49
Showing 1-25 of 49 citing articles:
Types of memory, dementia, Alzheimer’s disease, and their various pathological cascades as targets for potential pharmacological drugs
Ansab Akhtar, Siddharth Singh, Ravinder Kaushik, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102289-102289
Closed Access | Times Cited: 13
Ansab Akhtar, Siddharth Singh, Ravinder Kaushik, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102289-102289
Closed Access | Times Cited: 13
Artificial Intelligence and Technology Collaboratories: Innovating aging research and Alzheimer's care
Peter Abadir, Esther S. Oh, Rama Chellappa, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 3074-3079
Open Access | Times Cited: 8
Peter Abadir, Esther S. Oh, Rama Chellappa, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 3074-3079
Open Access | Times Cited: 8
Characteristics of adverse events and clinical risks of Lecanemab based on FAERS data
Zhaohui Li, Jun Gu, Zhiqiang Du, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 46-54
Closed Access | Times Cited: 1
Zhaohui Li, Jun Gu, Zhiqiang Du, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 46-54
Closed Access | Times Cited: 1
ADNet: deep learning based model for Alzheimer’s disease classification
Prashant Upadhyay, Pradeep Tomar, Satya Prakash Yadav
Iran Journal of Computer Science (2025)
Closed Access | Times Cited: 1
Prashant Upadhyay, Pradeep Tomar, Satya Prakash Yadav
Iran Journal of Computer Science (2025)
Closed Access | Times Cited: 1
Focusing on earlier diagnosis of Alzheimer's disease
Kristian Steen Frederiksen, Xavier Morató, Henrik Zetterberg, et al.
Future Neurology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Kristian Steen Frederiksen, Xavier Morató, Henrik Zetterberg, et al.
Future Neurology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 6
Evaluating p-tau217 and p-tau231 as Biomarkers for Early Diagnosis and Differentiation of Alzheimer’s Disease: A Narrative Review
Dorian Julian Jarek, Hubert Mizerka, Jarosław Nuszkiewicz, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 786-786
Open Access | Times Cited: 5
Dorian Julian Jarek, Hubert Mizerka, Jarosław Nuszkiewicz, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 786-786
Open Access | Times Cited: 5
Human serum albumin-3-amino-1-propanesulfonic acid conjugate inhibits amyloid-β aggregation and mitigates cognitive decline in Alzheimer's disease
Divya Shastri, Chaitany Jayprakash Raorane, Vinit Raj, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 390-408
Closed Access
Divya Shastri, Chaitany Jayprakash Raorane, Vinit Raj, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 390-408
Closed Access
Neural mechanism of cognitive reserve in acupuncture stimulation: A protocol for a randomized, placebo-controlled functional near-infrared spectroscopy (fNIRS) trial (Preprint)
Hyeonsang Shin, Woohyun Seong, Yeonju Woo, et al.
JMIR Research Protocols (2025) Vol. 14, pp. e66838-e66838
Open Access
Hyeonsang Shin, Woohyun Seong, Yeonju Woo, et al.
JMIR Research Protocols (2025) Vol. 14, pp. e66838-e66838
Open Access
In Silico Exploration of Cholinergic Activity and Neuroprotection of Novel Caffeine Analogues
Diego Javier Obiol, Agustín Vietri, Juan Pablo Munafó, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151374-151374
Closed Access
Diego Javier Obiol, Agustín Vietri, Juan Pablo Munafó, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151374-151374
Closed Access
Synthesis and biological evaluation of natural cleistanolate, its enantiomer and analogues
Jelena Kesić, Mirjana Popsavin, Goran Benedeković, et al.
European Journal of Medicinal Chemistry (2025), pp. 117326-117326
Closed Access
Jelena Kesić, Mirjana Popsavin, Goran Benedeković, et al.
European Journal of Medicinal Chemistry (2025), pp. 117326-117326
Closed Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's disease
Haitham Al‐Madhagi, Husam Nassar
Computers in Biology and Medicine (2025) Vol. 187, pp. 109781-109781
Closed Access
Haitham Al‐Madhagi, Husam Nassar
Computers in Biology and Medicine (2025) Vol. 187, pp. 109781-109781
Closed Access
Prevalence, incidence and demographics of dementia in Ecuador
José Alejandro Valdevila Figueira, Xavier Rodrigo Yambay Bautista, Indira Dayana Carvajal Parra, et al.
Research Square (Research Square) (2025)
Closed Access
José Alejandro Valdevila Figueira, Xavier Rodrigo Yambay Bautista, Indira Dayana Carvajal Parra, et al.
Research Square (Research Square) (2025)
Closed Access
Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models
Edna Grünblatt, Cristine Marie Yde Ohki, G Angelika Schmitt-Böhrer, et al.
Journal of Neural Transmission (2025)
Open Access
Edna Grünblatt, Cristine Marie Yde Ohki, G Angelika Schmitt-Böhrer, et al.
Journal of Neural Transmission (2025)
Open Access
Alpha Rhythm and Alzheimer’s Disease: Has Hans Berger’s Dream Come True?
Claudio Babiloni, Xianghong Arakaki, Sandra Báez, et al.
Clinical Neurophysiology (2025) Vol. 172, pp. 33-50
Open Access
Claudio Babiloni, Xianghong Arakaki, Sandra Báez, et al.
Clinical Neurophysiology (2025) Vol. 172, pp. 33-50
Open Access
Evaluating the causal effects of circulating metabolic biomarkers on Alzheimer's disease
Jianbin Du, Ancha Baranova, Hongbao Cao, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 138, pp. 111309-111309
Closed Access
Jianbin Du, Ancha Baranova, Hongbao Cao, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 138, pp. 111309-111309
Closed Access
Inhibitory Effects of Alkaloids Against Enzymes Linked to Neurodegenerative Diseases
İlkay Erdoğan Orhan, Fatma Sezer Şenol
Springer eBooks (2025), pp. 1-21
Closed Access
İlkay Erdoğan Orhan, Fatma Sezer Şenol
Springer eBooks (2025), pp. 1-21
Closed Access
Demographic and clinical characteristics of initial patients receiving amyloid‐targeting treatments in the United States after regulatory approval
Soeren Mattke, Susan Yue, A. C. Becker, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Soeren Mattke, Susan Yue, A. C. Becker, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Opposite causal effects of type 2 diabetes and metformin on Alzheimer's disease
Dongming Liu, Hongbao Cao, Ancha Baranova, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100129-100129
Open Access
Dongming Liu, Hongbao Cao, Ancha Baranova, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100129-100129
Open Access
Mechanism of nimodipine in treating neurodegenerative diseases: in silico target identification and molecular dynamic simulation
Shuang Zheng, Yin Wang, Shuainan Tang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Shuang Zheng, Yin Wang, Shuainan Tang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Gene Co-Expression Analysis Reveals Functional Differences Between Early- and Late-Onset Alzheimer’s Disease
Abel Isaías Gutiérrez Cruz, Guillermo de Anda‐Jáuregui, Enrique Hernández-Lemus
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 200-200
Open Access
Abel Isaías Gutiérrez Cruz, Guillermo de Anda‐Jáuregui, Enrique Hernández-Lemus
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 200-200
Open Access
Yoga an integrated mind body intervention for improvement in quality of life in individuals with Alzheimer’s disease and their caregivers
Meenakshi Kaushik, Anjali Yadav, Abhinav Upadhyay, et al.
Frontiers in Aging (2025) Vol. 6
Open Access
Meenakshi Kaushik, Anjali Yadav, Abhinav Upadhyay, et al.
Frontiers in Aging (2025) Vol. 6
Open Access
The Oral–Gut Microbiome–Brain Axis in Cognition
Noorul Ain Adil, Christabel Omo-Erigbe, Hariom Yadav, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 814-814
Open Access
Noorul Ain Adil, Christabel Omo-Erigbe, Hariom Yadav, et al.
Microorganisms (2025) Vol. 13, Iss. 4, pp. 814-814
Open Access
Ginsenoside CK modulates glucose metabolism via PPARγ to ameliorate SCOP-induced cognitive dysfunction
Na Li, Xingyu Fang, Hui Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Na Li, Xingyu Fang, Hui Li, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Closed Access
Mortality patterns in patients with type 2 diabetes mellitus and late-onset Alzheimer’s disease in the United States: a retrospective analysis from 1999 to 2020
Ahmed Raza, Eeshal Fatima, Abu Huraira Bin Gulzar, et al.
Neurological Sciences (2025)
Closed Access
Ahmed Raza, Eeshal Fatima, Abu Huraira Bin Gulzar, et al.
Neurological Sciences (2025)
Closed Access
